4/A//SEC Filing
Sprague John M 4/A
Accession 0000899243-22-012648
CIK 0001492674other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:23 PM ET
Size
9.1 KB
Accession
0000899243-22-012648
Insider Transaction Report
Form 4/AAmended
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-02-24−145,719→ 291,439 total→ Common Stock (145,719 underlying) - Tax Payment
Common Stock
2022-02-24$0.45/sh−55,008$24,688→ 142,350 total - Exercise/Conversion
Common Stock
2022-02-24+145,719→ 197,358 total
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The Form 4, as originally filed, incorrectly reported the amount of beneficially owned securities as 191,204.
- [F3]55,008 shares of common stock were automatically withheld at vesting to cover required tax withholding.
- [F4]The Form 4, as originally filed, incorrectly reported the amount of beneficially owned securities as 136,196.
- [F5]On February 24, 2021 the reporting person was granted 437,158 RSU's that vest in three equal installments commencing on February 24, 2022.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001730056
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 4:23 PM ET
- Size
- 9.1 KB